Literature DB >> 25854527

UDP-Glucuronosyltransferases 1A6 and 1A9 are the Major Isozymes Responsible for the 7-O-Glucuronidation of Esculetin and 4-Methylesculetin in Human Liver Microsomes.

Lijun Zhu1, Linlin Lu1, Shan Zeng1, Feifei Luo1, Peimin Dai1, Peng Wu1, Ying Wang1, Liang Liu1, Ming Hu1, Zhongqiu Liu2.   

Abstract

Esculetin (6,7-dihydroxycoumarin, ET) and 4-methylesculetin (6,7-dihydroxy-4-methylcoumarin, 4-ME) are typical coumarin derivatives that are attracting considerable attention because of their wide spectrum of biologic activities, but their metabolism remains unknown. This study aimed to elucidate the in vitro UDP-glucuronosyltransferase (UGT) metabolism characteristics of ET and 4-ME. 7-O-monoglucuronide esculetin (ET-G) and 7-O-monoglucuronide 4-methylesculetin (4-ME-G) were identified by liquid chromatography-mass spectrometry (LC-MS) and (1)H-nuclear magnetic resonance ((1)HNMR) when ET or 4-ME was incubated with human liver (HLM) in the presence of UDP-glucuronic acid. Screening assays with 12 human expressed UGTs demonstrated that the formations of ET-G and 4-ME-G were almost exclusively catalyzed by UGT1A6 and UGT1A9. Phenylbutazone and carvacrol (UGT1A6 and UGT1A9 chemical inhibitors, respectively) at different concentrations (50, 100, and 200 μM) significantly inhibited the formation of glucuronidates of ET and 4-ME in HLM, UGT1A6, and UGT1A9 when the concentrations of ET and 4-ME ranged from 10 to 300 μM (P < 0.05). Clearance rates of ET in HLM, HIM, UGT1A6, and UGT1A9 were 0.54, 0.16, 0.69, and 0.14 ml/min/mg, respectively. Corresponding clearance rates values of 4-ME were 0.59, 0.03, 0.14, and 0.04 ml/min/mg, respectively. In conclusion, 7-O-monoglucuronidation by UGT1A6 and UGT1A9 was the predominant UGT metabolic pathway for both ET and 4-ME in vitro. The liver is probably the major contributor to the glucuronidation metabolism of ET and 4-ME. ET showed more rapid metabolism than 4-ME in glucuronidation.
Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25854527      PMCID: PMC6067388          DOI: 10.1124/dmd.115.063552

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  27 in total

1.  Identification and characterization of human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation of daphnetin.

Authors:  Si-Cheng Liang; Guang-Bo Ge; Hui-Xin Liu; Yan-Yan Zhang; Li-Ming Wang; Jiang-Wei Zhang; Lu Yin; Wei Li; Zhong-Ze Fang; Jing-Jing Wu; Guo-Hui Li; Ling Yang
Journal:  Drug Metab Dispos       Date:  2010-02-22       Impact factor: 3.922

2.  Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-04

3.  Identification of the human UDP-glucuronosyltransferases involved in the glucuronidation of combretastatin A-4.

Authors:  Silvio Aprile; Erika Del Grosso; Giorgio Grosa
Journal:  Drug Metab Dispos       Date:  2010-04-07       Impact factor: 3.922

Review 4.  Coumarin metabolism, toxicity and carcinogenicity: relevance for human risk assessment.

Authors:  B G Lake
Journal:  Food Chem Toxicol       Date:  1999-04       Impact factor: 6.023

5.  Selectivity of substrate (trifluoperazine) and inhibitor (amitriptyline, androsterone, canrenoic acid, hecogenin, phenylbutazone, quinidine, quinine, and sulfinpyrazone) "probes" for human udp-glucuronosyltransferases.

Authors:  Verawan Uchaipichat; Peter I Mackenzie; David J Elliot; John O Miners
Journal:  Drug Metab Dispos       Date:  2005-12-28       Impact factor: 3.922

6.  Anti-inflammatory and peripheral analgesic activity of esculetin in vivo.

Authors:  A Tubaro; P Del Negro; E Ragazzi; S Zampiron; R Della Loggia
Journal:  Pharmacol Res Commun       Date:  1988-12

7.  Protective effect of esculetin against oxidative stress-induced cell damage via scavenging reactive oxygen species.

Authors:  So-hyung Kim; Kyoung-ah Kang; Rui Zhang; Mei-jing Piao; Dong-ok Ko; Zhi-hong Wang; Sung-wook Chae; Sam-sik Kang; Keun-hwa Lee; Hee-kyoung Kang; Hyun-wook Kang; Jin-won Hyun
Journal:  Acta Pharmacol Sin       Date:  2008-11       Impact factor: 6.150

8.  Induction of apoptosis by esculetin in human leukemia U937 cells through activation of JNK and ERK.

Authors:  Cheol Park; Cheng-Yun Jin; Gi-Young Kim; Il-Whan Choi; Taeg Kyu Kwon; Byung Tae Choi; Su Jae Lee; Won Ho Lee; Yung Hyun Choi
Journal:  Toxicol Appl Pharmacol       Date:  2007-10-12       Impact factor: 4.219

9.  Interactions of a series of coumarins with reactive oxygen species. Scavenging of superoxide, hypochlorous acid and hydroxyl radicals.

Authors:  M Payá; B Halliwell; J R Hoult
Journal:  Biochem Pharmacol       Date:  1992-07-22       Impact factor: 5.858

Review 10.  Review on natural coumarin lead compounds for their pharmacological activity.

Authors:  K N Venugopala; V Rashmi; B Odhav
Journal:  Biomed Res Int       Date:  2013-03-24       Impact factor: 3.411

View more
  2 in total

1.  Metabolic Disposition of Luteolin Is Mediated by the Interplay of UDP-Glucuronosyltransferases and Catechol-O-Methyltransferases in Rats.

Authors:  Liping Wang; Qingwei Chen; Lijun Zhu; Qiang Li; Xuejun Zeng; Linlin Lu; Ming Hu; Xinchun Wang; Zhongqiu Liu
Journal:  Drug Metab Dispos       Date:  2016-12-28       Impact factor: 3.922

2.  Regioselective Glucuronidation of Diosmetin and Chrysoeriol by the Interplay of Glucuronidation and Transport in UGT1A9-Overexpressing HeLa Cells.

Authors:  Xuejun Zeng; Jian Shi; Min Zhao; Qingwei Chen; Liping Wang; Huangyu Jiang; Feifei Luo; Lijun Zhu; Linlin Lu; Xinchun Wang; Zhongqiu Liu
Journal:  PLoS One       Date:  2016-11-10       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.